Solasia Pharma KK (FRA:9SO) FCF Margin %: -1,039.39% (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:9SO Solasia Pharma KK FRA:9SO
50 GF Score
Price €0.12
GF Value €0.01
Valuation Significantly Overvalued
! 6 Warning Signs
View Full Analysis

What is Solasia Pharma KK FCF Margin %?

Solasia Pharma KK FRA:9SO +4.31% 50 FCF Margin % is -1,039.39% as of Mar. 2026. GuruFocus rates FRA:9SO with a GF Score™ of 50/100 and a GF Value™ of €0.01 (Significantly Overvalued). The stock has 6 warning signs investors should review. Among 963 Drug Manufacturers companies, Solasia Pharma KK ranks worse than 96.47% on this metric.

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Solasia Pharma KK's Free Cash Flow for the three months ended in Mar. 2026 was €-0.34 Mil. Solasia Pharma KK's Revenue for the three months ended in Mar. 2026 was €0.03 Mil. Therefore, Solasia Pharma KK's FCF Margin % for the quarter that ended in Mar. 2026 was -1,039.39%.

As of today, Solasia Pharma KK's current FCF Yield % is -4.15%.

The historical rank and industry rank for Solasia Pharma KK's FCF Margin % or its related term are showing as below:

FRA:9SO' s FCF Margin % Range Over the Past 10 Years
Min: -1017.51   Med: -327.22   Max: -58.18
Current: -1017.51

During the past 13 years, the highest FCF Margin % of Solasia Pharma KK was -58.18%. The lowest was -1017.51%. And the median was -327.22%.

FRA:9SO's FCF Margin % is ranked worse than
96.47% of 963 companies
in the Drug Manufacturers industry
Industry Median: 2.57 vs FRA:9SO: -1017.51

Solasia Pharma KK FCF Margin % Related Terms

Solasia Pharma KK FCF Margin % Historical Data

* Premium members only.

The historical data trend for Solasia Pharma KK's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Solasia Pharma KK FCF Margin % Chart

Solasia Pharma KK Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
FCF Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -471.54 -226.83 -58.17 -327.22 0.00

Solasia Pharma KK Quarterly Data
Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
FCF Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 844.52 -1,012.50 0.00 0.00 -1,039.39

FRA:9SO vs ZTS, UTHR: FCF Margin % Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Solasia Pharma KK's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Solasia Pharma KK FCF Margin % vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Solasia Pharma KK's FCF Margin % distribution charts can be found below:

* The bar in red indicates where Solasia Pharma KK's FCF Margin % falls into.


FRA:9SO
50GF Score
Solasia Pharma KK FRA:9SO
FCF Margin % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Solasia Pharma KK FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

Solasia Pharma KK's FCF Margin for the fiscal year that ended in Dec. 2025 is calculated as

FCF Margin=Free Cash Flow (A: Dec. 2025 )/Revenue (A: Dec. 2025 )
=0/2.35
=0.00 %

Solasia Pharma KK's FCF Margin for the quarter that ended in Mar. 2026 is calculated as

FCF Margin=Free Cash Flow (Q: Mar. 2026 )/Revenue (Q: Mar. 2026 )
=-0.343/0.033
=-1,039.39 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about FCF Margin % →
What does a FCF Margin % of -1,039.39% mean?
Solasia Pharma KK (FRA:9SO) has a FCF Margin % of -1,039.39% as of Mar. 2026. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Solasia Pharma KK and its competitors. According to the industry distribution chart, Solasia Pharma KK ranks #929 out of 963 companies in the Drug Manufacturers industry, placing it in the top 96.5%.
Is Solasia Pharma KK's FCF Margin % too high?
Solasia Pharma KK's current FCF Margin % is -1,039.39%. Based on the distribution chart, Solasia Pharma KK ranks #929 out of 963 companies in the Drug Manufacturers industry, which is in the bottom quartile relative to peers. Overall, Solasia Pharma KK has a GF Score™ of 50/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Solasia Pharma KK's FCF Margin % compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Solasia Pharma KK ranks #929 out of 963 companies for FCF Margin %. This places Solasia Pharma KK in the lower half of its industry. The industry median FCF Margin % is 2.57. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Margin % for a Drug Manufacturers company?
The median FCF Margin % among Drug Manufacturers companies is 2.57, based on 963 companies in the industry. Companies in the top quartile (top 25%) have a FCF Margin % significantly above this median, while those in the bottom quartile fall well below. However, FCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Margin % mean?
A high FCF Margin % can signal that a stock is expensive relative to its fundamentals. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Solasia Pharma KK and its competitors. For the Drug Manufacturers industry, the median FCF Margin % is 2.57 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Solasia Pharma KK's current FCF Margin % is -1,039.39%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Solasia Pharma KK stock overvalued right now?
Based on GuruFocus' analysis, Solasia Pharma KK (FRA:9SO) is currently considered Significantly Overvalued. The stock's GF Value™ is €0.01, compared to a current price of €0.12 — trading 1110% above its estimated fair value. The current FCF Margin % is -1,039.39%. Solasia Pharma KK's overall GF Score™ is 50/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Margin % calculated?
FCF Margin % is calculated from a company's financial statements. For Solasia Pharma KK (FRA:9SO), the current FCF Margin % is -1,039.39% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Solasia Pharma KK (FRA:9SO) Overvalued in 2026?

Based on GuruFocus' analysis, Solasia Pharma KK stock appears to be overvalued. The current stock price of €0.12 is trading 1110% above its estimated GF Value™ of €0.01. GuruFocus considers Solasia Pharma KK to be Significantly Overvalued.

Key valuation signals for FRA:9SO:

  • FCF Margin %: -1,039.39%
  • GF Value™: €0.01 vs. price of €0.12 (1110% above fair value)
  • GF Score™: 50/100 with 6 warning signs

No single metric tells the full story. See the FRA:9SO stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Solasia Pharma KK Business Description

Other Exchanges 4597:Japan
Address 2-1-1 Shiba Park, 4th Floor, Sumitomo Real Estate Shiba Park Tower, Minato-ku, Tokyo, JPN, 105-0011
Solasia Pharma KK develops and distributes pharmaceuticals and medical devices relating to malignant tumors.
50GF Score

Get the complete analysis for FRA:9SO

FCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€0.12
Price
€0.01
GF Value